[HTML][HTML] Seroconversion rates following COVID-19 vaccination among patients with cancer
As COVID-19 adversely affects patients with cancer, prophylactic strategies are critically
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …
[引用][C] Seroconversion rates following COVID-19 vaccination among patients with cancer
A Thakkar, JD Gonzalez-Lugo, N Goradia, R Gali… - Cancer Cell, 2021 - cir.nii.ac.jp
Seroconversion rates following COVID-19 vaccination among patients with cancer | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
[HTML][HTML] Seroconversion rates following COVID-19 vaccination among patients with cancer
A Thakkar, JD Gonzalez-Lugo, N Goradia, R Gali… - Cancer Cell, 2021 - cell.com
As COVID-19 adversely affects patients with cancer, prophylactic strategies are critically
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …
[HTML][HTML] Seroconversion rates following COVID-19 vaccination among patients with cancer
A Thakkar, JD Gonzalez-Lugo, N Goradia, R Gali… - Cancer Cell, 2021 - Elsevier
As COVID-19 adversely affects patients with cancer, prophylactic strategies are critically
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …
Seroconversion rates following COVID-19 vaccination among patients with cancer
A Thakkar, JD Gonzalez-Lugo, N Goradia… - Cancer …, 2021 - ohiostate.elsevierpure.com
As COVID-19 adversely affects patients with cancer, prophylactic strategies are critically
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …
[HTML][HTML] Seroconversion rates following COVID-19 vaccination among patients with cancer
A Thakkar, JD Gonzalez-Lugo, N Goradia, R Gali… - Cancer Cell, 2021 - ncbi.nlm.nih.gov
As COVID-19 adversely affects patients with cancer, prophylactic strategies are critically
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …
Seroconversion rates following COVID-19 vaccination among patients with cancer
A Thakkar, JD Gonzalez-Lugo, N Goradia… - Cancer …, 2021 - einstein.elsevierpure.com
As COVID-19 adversely affects patients with cancer, prophylactic strategies are critically
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …
[PDF][PDF] Seroconversion rates following COVID-19 vaccination among patients with cancer
A Thakkar, JD Gonzalez-Lugo, N Goradia, R Gali… - Cancer Cell, 2021 - academia.edu
As COVID-19 adversely affects patients with cancer, prophylactic strategies are critically
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …
Seroconversion rates following COVID-19 vaccination among patients with cancer
A Thakkar, JD Gonzalez-Lugo, N Goradia… - Cancer …, 2021 - pubmed.ncbi.nlm.nih.gov
As COVID-19 adversely affects patients with cancer, prophylactic strategies are critically
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …
Seroconversion rates following COVID-19 vaccination among patients with cancer.
A Thakkar, JD Gonzalez-Lugo, N Goradia, R Gali… - Cancer Cell, 2021 - europepmc.org
As COVID-19 adversely affects patients with cancer, prophylactic strategies are critically
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …